Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Spence

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|November 21, 2018
Statin use and survival in patients with gastric cancer in two independent population-based cohortsAndrew D Spence, John Busby, Carmel M Hughes, et al.
Gastroenterology|November 11, 2017
Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric CancerAndrew D Spence, John Busby, Brian T Johnston, et al.
BMC Gastroenterology|December 13, 2017
Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic reviewAndrew D Spence, Chris R Cardwell, Úna C McMenamin, et al.
United European Gastroenterology Journal|October 6, 2018
Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK BiobankAndrew T Kunzmann, Kristian P Mallon, Ruth F Hunter, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2017
Blood biomarkers for early diagnosis of oesophageal cancer: a systematic reviewAndrew T Kunzmann, Úna C McMenamin, Andrew D Spence, et al.
International Journal of Cancer|March 14, 2018
Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK BiobankÚna C Mc Menamin, Andrew T Kunzmann, Michael B Cook, et al.
Pharmacoepidemiology and Drug Safety|November 13, 2019
The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control studyJohn Busby, Reema Karasneh, Peter Murchie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2018
Model for Identifying Individuals at Risk for Esophageal AdenocarcinomaAndrew T Kunzmann, Aaron P Thrift, Chris R Cardwell, et al.
Histopathology|November 9, 2018
High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort studyAndrew D Spence, James Trainor, Úna McMenamin, et al.
International Journal of Cancer|February 4, 2018
Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databasesAndrew D Spence, John Busby, Peter Murchie, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|November 21, 2018
Statin use and survival in patients with gastric cancer in two independent population-based cohortsAndrew D Spence, John Busby, Carmel M Hughes, et al.
Gastroenterology|November 11, 2017
Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric CancerAndrew D Spence, John Busby, Brian T Johnston, et al.
BMC Gastroenterology|December 13, 2017
Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic reviewAndrew D Spence, Chris R Cardwell, Úna C McMenamin, et al.
United European Gastroenterology Journal|October 6, 2018
Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK BiobankAndrew T Kunzmann, Kristian P Mallon, Ruth F Hunter, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2017
Blood biomarkers for early diagnosis of oesophageal cancer: a systematic reviewAndrew T Kunzmann, Úna C McMenamin, Andrew D Spence, et al.
International Journal of Cancer|March 14, 2018
Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK BiobankÚna C Mc Menamin, Andrew T Kunzmann, Michael B Cook, et al.
Pharmacoepidemiology and Drug Safety|November 13, 2019
The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control studyJohn Busby, Reema Karasneh, Peter Murchie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2018
Model for Identifying Individuals at Risk for Esophageal AdenocarcinomaAndrew T Kunzmann, Aaron P Thrift, Chris R Cardwell, et al.
Histopathology|November 9, 2018
High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort studyAndrew D Spence, James Trainor, Úna McMenamin, et al.
International Journal of Cancer|February 4, 2018
Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databasesAndrew D Spence, John Busby, Peter Murchie, et al.
Pageof 3